Table 2. Inclusion criteria.
Male of female between 20 and 80 years of age |
Type 2 diabetic patients with coronary artery disease who require PCI |
The presence of mild stenosis in the non-target vessel (% diameter stenosis between 10–50%) |
7.0%≤ HbA1c ≤10.0% |
HbA1c ≤10.0% in subjects who receive insulin, sulfonylurea or nateglinide |
Ability to understand the requirements of the study and to provide informed consent |
HbA1c, glycated hemoglobin; PCI, percutaneous coronary intervention.